Research & Development



  劉萍撥弄著隋越帽子上的三條金邊喃喃自語道︰“居然真的是未央宮的大長秋……我記得送我離開長安的人,也是大長秋,名字叫崔安……他說過,要我忍耐幾年,就會把我接回去,沒想到這一等,就是五十年……”   對他來說,留在長門宮,比留在長安城更讓他安心。牛牛视频超碰在线福利   七八年前,當陽陵邑的房子,店鋪用莢錢都能購買的時候,雲氏的婆子們早就人手一座宅院了。超碰在线观看   狗子笑道︰“獎賞,懲處,是你的事情,家主不會一竿子通到底的,弟子把事情辦得不錯,勉勵幾句還是必須的。” 超碰在线视频caoporon   慘叫聲非常的短促,就那麼幾聲,然後就迅速的遠遁了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo